Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1995;91:1016-1021

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zimmermann, R.
Right arrow Articles by Kübler, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zimmermann, R.
Right arrow Articles by Kübler, W.

(Circulation. 1995;91:1016-1021.)
© 1995 American Heart Association, Inc.


Articles

Residual 201Tl Activity in Irreversible Defects as a Marker of Myocardial Viability

Clinicopathological Study

Presented in part at the 66th Scientific Sessions of the American Heart Association, Atlanta, Ga, November 8-11, 1993.

Rainer Zimmermann, MD; Gerhard Mall, MD; Bernhard Rauch, MD; Gisela Zimmer, MD; Michael Gabel, MD; Jörg Zehelein, MD; Bernd Bubeck, MD; Harald Tillmanns, MD; Siegfried Hagl, MD; Wolfgang Kübler, MD

From the Department of Cardiology (R.Z., B.R., J.Z., W.K.), the Institute of Pathology (G.M., M.G.), the Institute for Forensic Medicine (G.Z.), and the Departments of Nuclear Medicine (B.B.) and Cardiac Surgery (S.H.), Ruprecht-Karls-University, Heidelberg, and the Department of Cardiology (H.T.), University of Gießen (Germany).

Correspondence to Rainer Zimmermann, MD, Department of Cardiology, Ruprecht-Karls-University, Bergheimer Str 58, D-69115 Heidelberg, FRG.

Background The objective of the present study was to characterize the relation between the residual 201Tl activity in irreversible perfusion defects and the extent of irreversible myocardial damage indicated by the volume fraction of myocardial interstitial fibrosis in patients with chronic coronary artery disease.

Methods and Results Stress planar 201Tl scintigraphy with tracer reinjection at rest was performed in 37 patients with >=75% stenosis of the left anterior descending coronary artery, and anteroseptal 201TI activity was quantified by computer-assisted placement of regions of interest from the serial myocardial images. During coronary artery bypass grafting (performed within 6±3 weeks after scintigraphy), two transmural biopsy specimens were taken from the anterior wall of the left ventricle and the amount of interstitial fibrosis was assessed by use of light microscopic morphometry. A wide spectrum of interstitial fibrosis was obtained, ranging from 15 vol% to 60 vol%. Interstitial fibrosis was similar in patients with reversible (n=11) or irreversible (n=15) tracer defects in conventional stress-redistribution images. However, interstitial fibrosis was significantly lower in patients who had enhanced regional 201Tl activity after tracer reinjection compared with those who did not have enhancement of tracer activity after reinjection (28±8 vol%, n=7, versus 41±12 vol%, n=8; P=.031). The correlation between relative poststenotic 201Tl activity and interstitial fibrosis after tracer reinjection was significantly improved compared with conventional redistribution images (r=-.622 versus r=-.851, n=15; P<.01).

Conclusions The present data demonstrate that the level of regional 201Tl activity in redistribution and, in particular, reinjection images is significantly related to the mass of preserved viable myocytes in poststenotic left ventricular myocardium. Therefore, the residual 201Tl activity provides information about viability within irreversible perfusion defects and may itself serve as marker of myocardial viability.


Key Words: coronary disease • myocardium • imaging • stenosis




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
H. P. Kuhl, A. M. Beek, A. P. van der Weerdt, M. B. M. Hofman, C. A. Visser, A. A. Lammertsma, N. Heussen, F. C. Visser, and A. C. van Rossum
Myocardial viability inchronic ischemic heart disease: Comparison of contrast-enhanced magnetic resonance imaging with 18F-fluorodeoxyglucose positron emission tomography
J. Am. Coll. Cardiol., April 16, 2003; 41(8): 1341 - 1348.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
I. Matsunari, J. Taki, and N. Tonami
Sequential Strategy Using Multimodality Viability Tests: Does It Work?
J. Nucl. Med., June 1, 2002; 43(6): 803 - 805.
[Full Text] [PDF]


Home page
JNMHome page
M. Faraggi
The Continuing Story of 201Tl Reverse Redistribution: Reverse Redistribution Is Still Alive, but Is the Myocardium Still Viable?
J. Nucl. Med., May 1, 2002; 43(5): 628 - 631.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. Shirani, J. Lee, R. Quigg, R. Pick, S. L. Bacharach, and V. Dilsizian
Relation of thallium uptake to morphologic features of chronic ischemic heart disease: evidence for myocardial remodeling in noninfarcted myocardium
J. Am. Coll. Cardiol., July 1, 2001; 38(1): 84 - 90.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. M. Cwajg, E. Cwajg, S. F. Nagueh, Z.-X. He, U. Qureshi, L. I. Olmos, M. A. Quinones, M. S. Verani, W. L. Winters, and W. A. Zoghbi
End-diastolic wall thickness as a predictor of recovery of function in myocardial hibernation: Relation to rest-redistribution Tl-201 tomography and dobutamine stress echocardiography
J. Am. Coll. Cardiol., April 1, 2000; 35(5): 1152 - 1161.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. Samady, J. A. Elefteriades, B. G. Abbott, J. A. Mattera, C. A. McPherson, and F. J. Th. Wackers
Failure to Improve Left Ventricular Function After Coronary Revascularization for Ischemic Cardiomyopathy Is Not Associated With Worse Outcome
Circulation, September 21, 1999; 100(12): 1298 - 1304.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. F. Nagueh, I. Mikati, D. Weilbaecher, M. J. Reardon, G. J. Al-Zaghrini, D. Cacela, Z.-X. He, G. Letsou, G. Noon, J. F. Howell, et al.
Relation of the Contractile Reserve of Hibernating Myocardium to Myocardial Structure in Humans
Circulation, August 3, 1999; 100(5): 490 - 496.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
M Faraggi, G Montalescot, L Sarda, J F Heintz, D Doumit, G Drobinski, I Sotirov, D Le Guludec, and D Thomas
Spontaneous late improvement of myocardial viability in the chronic infarct zone is possible, depending on persistent TIMI 3 flow and a low grade stenosis of the infarct artery
Heart, April 1, 1999; 81(4): 424 - 430.
[Abstract] [Full Text]


Home page
CirculationHome page
A. N. Kitsiou, G. Srinivasan, A. A. Quyyumi, R. M. Summers, S. L. Bacharach, and V. Dilsizian
Stress-Induced Reversible and Mild-to-Moderate Irreversible Thallium Defects : Are They Equally Accurate for Predicting Recovery of Regional Left Ventricular Function After Revascularization?
Circulation, August 11, 1998; 98(6): 501 - 508.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
W. Wijns, S. F. Vatner, and P. G. Camici
Hibernating Myocardium
N. Engl. J. Med., July 16, 1998; 339(3): 173 - 181.
[Full Text] [PDF]


Home page
CirculationHome page
H. A. Dakik, J. F. Howell, G. M. Lawrie, R. Espada, D. G. Weilbaecher, Z.-X. He, J. J. Mahmarian, and M. S. Verani
Assessment of Myocardial Viability With 99mTc-Sestamibi Tomography Before Coronary Bypass Graft Surgery : Correlation With Histopathology and Postoperative Improvement in Cardiac Function
Circulation, November 4, 1997; 96(9): 2892 - 2898.
[Abstract] [Full Text]


Home page
CirculationHome page
U. Qureshi, S. F. Nagueh, I. Afridi, P. Vaduganathan, A. Blaustein, M. S. Verani, W. L. Winters, and W. A. Zoghbi
Dobutamine Echocardiography and Quantitative Rest-Redistribution 201Tl Tomography in Myocardial Hibernation: Relation of Contractile Reserve to 201Tl Uptake and Comparative Prediction of Recovery of Function
Circulation, February 4, 1997; 95(3): 626 - 635.
[Abstract] [Full Text]


Home page
CirculationHome page
R. O. Bonow
Identification of Viable Myocardium
Circulation, December 1, 1996; 94(11): 2674 - 2680.
[Full Text]


Home page
CirculationHome page
R. Medrano, R. W. Lowry, J. B. Young, D. G. Weilbaecher, L. H. Michael, I. Afridi, Z.-X. He, J. J. Mahmarian, and M. S. Verani
Assessment of Myocardial Viability With 99mTc Sestamibi in Patients Undergoing Cardiac Transplantation: A Scintigraphic/Pathological Study
Circulation, September 1, 1996; 94(5): 1010 - 1017.
[Abstract] [Full Text]